Skip to content

Takato Hiranita

4 papers in the library · publishing 2010-2026

Papers

Sort Most recent Most cited

The Sigma1 receptor antagonist CM304 potentiates the antinociceptive effects of the cannabinoid receptor agonist delta9-tetrahydrocannabinol in rats and mice.

Pharmacological reports : PR April 1, 2026 Elmira Zolali, Mallory Burns, Sebastiano Intagliata et al.

BACKGROUND: Mu opioid receptor (MOR) agonists are the primary medication class used to treat moderate to severe pain; however, the ongoing opioid overdose crisis underscores the need for alternatives to MOR agonists for pain treatment. Delta9-tetrahydrocannabinol (THC), a cannabinoid CB1 receptor (CB1R) agonist, and sigma1 receptor (σ1R) antagonists elicit antinociceptive effects albeit less...

Effects of cannabis smoke and oral Δ9THC on cognition in young adult and aged rats

Psychopharmacology February 7, 2025 Sabrina Zequeira, Emely A. Gazarov, Alara A. Güvenli et al.

With increasing legalization of recreational and medical cannabis, use of this drug is growing rapidly among older adults. As cannabis can impair cognition in young adults, it is critically important to understand how its consumption interacts with the cognitive profile of aged subjects, who are already at increased risk of decline. The current study was designed to determine how cannabis...

Cannabis smoke and oral Δ9THC enhance working memory in aged but not young adult subjects

bioRxiv (Cold Spring Harbor Laboratory) September 29, 2024 Sabrina Zequeira, Emely A. Gazarov, Alara A. Güvenli et al. preprint

With increased legalization of recreational and medical cannabis, use of this drug is growing rapidly among older adults. As cannabis use can impair cognition in young adults, it is critically important to understand how consumption interacts with the cognitive profile of aged individuals, who are already at increased risk of decline. The current study was designed to determine how cannabis...

A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology January 2010 Yoko Nawata, Takato Hiranita, Tsuneyuki Yamamoto

(+/-)-3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') abusers have persistent neuropsychiatric deficits including memory impairments after the cessation of abuse. On the other hand, cannabinoid CB(1) receptors have been implicated in learning/memory, and are highly expressed in the hippocampus, a region of the brain believed to have an important function in certain forms of learning and...